Atlas Trials

A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate

Clinical trial NCT05349435 · TERMINATED

Trial details

NCT number
NCT05349435
Sponsor
Liminal BioSciences Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperammonemia
Start date
2022-05-13
Primary completion
2022-06-30
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.